hoe 33342 and Acute Myelogenous Leukemia

hoe 33342 has been researched along with Acute Myelogenous Leukemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbott, BL	1
Preisler, HD; Rustum, YM	1

Reviews

1 review(s) available for hoe 33342 and Acute Myelogenous Leukemia

Article	Year
ABCG2 (BCRP) expression in normal and malignant hematopoietic cells. Hematological oncology, 2003, Volume: 21, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Fluorescent Dyes; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Models, Biological; Models, Chemical; Neoplasm Proteins; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase Inhibitors	2003

Article

Year

ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.

Hematological oncology, 2003, Volume: 21, Issue:3

Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Fluorescent Dyes; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Models, Biological; Models, Chemical; Neoplasm Proteins; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase Inhibitors

2003

Other Studies

1 other study(ies) available for hoe 33342 and Acute Myelogenous Leukemia

Article	Year
Prediction of therapeutic response in acute myelocytic leukemia. Haematology and blood transfusion, 1979, Volume: 23 Topics: Arabinofuranosylcytosine Triphosphate; Benzimidazoles; Biological Transport; Cytarabine; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Fluorescence; Fluorescent Dyes; Humans; Leukemia, Myeloid, Acute; Phosphorylation	1979